Announcements Trials

Browse Landscape

Status

Recruiting 4 Completed 4 Unknown 3 Terminated 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasm Metastasis 2 Breast Neoplasms 2 Brain Neoplasms 2 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Speech 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms 1 Gastrointestinal Stromal Tumors 1 Gastrointestinal Neoplasms 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Hepatocellular 1

Interventions

Gemcitabine 34 pembrolizumab 26 Paclitaxel 21 Cyclophosphamide 21 Docetaxel 20 Carboplatin 20 Irinotecan 19 Capecitabine 19 Fluorouracil 17 Bevacizumab 15 Dexamethasone 14 fludarabine 13 Oxaliplatin 13 Leucovorin 13 Blood Specimen Collection 13 Everolimus 12 Cetuximab 12 Ipilimumab 11 Erlotinib Hydrochloride 11 Rituximab 10 Pemetrexed 10 Cisplatin 10 venetoclax 9 Temozolomide 9 Sunitinib 9 Nivolumab 9 Trastuzumab 8 Interleukin-2 8 aldesleukin 7 Epoetin Alfa 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Neoplasms × Quality of Life × Clear all

NCT03425435 2022-02-01

VHPE-S

Fresenius Kabi

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡